Literature DB >> 8251041

Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors.

L R Barrows1, D C Radisky, B R Copp, D S Swaffar, R A Kramer, R L Warters, C M Ireland.   

Abstract

The makaluvamines were isolated from a sponge of the genus Zyzzya by following bioactivity against the human colon carcinoma cell line, HCT 116. These compounds have considerable cytotoxic activity. The makaluvamines appear to be acting through inhibition of DNA topoisomerase II. The compounds show enhanced toxicity toward a topoisomerase II-cleavable complex-sensitive cell line, they inhibit topoisomerase II decatenation of kinetoplast DNA in vitro. Makaluvamine C was shown to produce protein-linked DNA double-strand breaks, and makaluvamine A produced DNA double-strand breaks by neutral filter elution in a dose-dependent fashion similar to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). The makaluvamines also increased the life span of nude mice bearing solid tumors of human ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251041

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  13 in total

1.  Study of molecular interactions by hydrogen bond of charged forms of makaluvamines and complex stability with H2O and glutamic acid (Glu Ac) by the theory of the functional of density (B3LYP).

Authors:  Sékou Diomandé; Affoué Lucie Bédé; Soleymane Koné; El-Hadji Sawaliho Bamba
Journal:  J Mol Model       Date:  2019-11-13       Impact factor: 1.810

2.  Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.

Authors:  Scharri J Ezell; Haibo Li; Hongxia Xu; Xiangrong Zhang; Evrim Gurpinar; Xu Zhang; Elizabeth R Rayburn; Charnell I Sommers; Xinyi Yang; Sadanandan E Velu; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2010-07-13       Impact factor: 5.118

3.  FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.

Authors:  Feng Wang; Scharri J Ezell; Yong Zhang; Wei Wang; Elizabeth R Rayburn; Dwayaja H Nadkarni; Srinivasan Murugesan; Sadanandan E Velu; Ruiwen Zhang
Journal:  Invest New Drugs       Date:  2009-03-10       Impact factor: 3.850

Review 4.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

5.  Selective cytotoxic activity of the marine-derived batzelline compounds against pancreatic cancer cell lines.

Authors:  Esther A Guzmán; Jacob D Johnson; Megan K Carrier; Cara I Meyer; Tara P Pitts; Sarath P Gunasekera; Amy E Wright
Journal:  Anticancer Drugs       Date:  2009-02       Impact factor: 2.248

6.  Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.

Authors:  Tao Chen; Yi Xu; He Guo; Yanling Liu; Pingting Hu; Xinying Yang; Xiaoguang Li; Shichao Ge; Sadanandan E Velu; Dwayaja H Nadkarni; Wei Wang; Ruiwen Zhang; Hui Wang
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

7.  Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.

Authors:  Xiangrong Zhang; Hongxia Xu; Xu Zhang; Sukesh Voruganti; Srinivasan Murugesan; Dwayaja H Nadkarni; Sadanandan E Velu; Ming-Hai Wang; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2012-05-23       Impact factor: 6.085

Review 8.  Anticancer properties of lamellarins.

Authors:  Christian Bailly
Journal:  Mar Drugs       Date:  2015-02-19       Impact factor: 5.118

9.  Design, synthesis and evaluation of new marine alkaloid-derived pentacyclic structures with anti-tumoral potency.

Authors:  Sebastien Boucle; Celine Melin; Marc Clastre; Jerome Guillard
Journal:  Mar Drugs       Date:  2015-01-19       Impact factor: 5.118

10.  Evaluation of the Antioxidant Activity of the Marine Pyrroloiminoquinone Makaluvamines.

Authors:  Eva Alonso; Rebeca Alvariño; Marta Leirós; Jioji N Tabudravu; Klaus Feussner; Miriam A Dam; Mostafa E Rateb; Marcel Jaspars; Luis M Botana
Journal:  Mar Drugs       Date:  2016-10-27       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.